Gemoscan Canada Inc.  

(Public, CVE:GES)   Watch this stock  
Find more results for GES
0.00000 (0.00%)
Aug 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.00 - 0.08
Open     -
Vol / Avg. 0.00/6,573.00
Mkt cap 192,080.00
P/E     -
Div/yield     -
EPS -0.05
Shares 37.62M
Beta 1.63
Inst. own     -

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin -29.17% -82.26%
Operating margin -16.56% -55.70%
EBITD margin - -37.60%
Return on average assets -95.89% -151.32%
Return on average equity - -
Employees 13 -
CDP Score - -


5000 Dufferin Street, Unit D1
+1-416-6501200 (Phone)
+1-416-6505700 (Fax)

Website links


Gemoscan Canada, Inc. is a Canada-based company that provides food intolerance management solutions and services. Gemoscan develops, owns and markets food sensitivity and dietary management solutions for consumers, including the HEMOCODE Food Intolerance System, MenuWise Food Intolerance Plan and personalized naturopathic nutritional programs that promote well-being. Gemoscan also owns and operates multidisciplinary paramedical clinics, Physiomed Kennedy Inc. and Physiomed Yorkdale Inc., which are located in Toronto, Ontario. The Company commercializes a food intolerance management solution directly to consumers in partnership with retailers. Gemoscan solutions use its technology and services to identify and manage food sensitivities while providing ongoing consultation and recommendations for dietary change, including nutritional supplements. The Company through Hemocode USA, Inc. sells and markets Hemocode and other food sensitivity management programs.

Officers and directors

Brian Kalish President, Chief Executive Officer, Director
Age: 42
Stephen M. Gledhill Chief Financial Officer, Secretary
Age: 50
Kathleen E Skerrett Director
James N. Jones Independent Director
Age: 62
Jack Steckel Independent Director
Scott E. Wilson Independent Director
Age: 42